PGNY - Progyny, Inc.
17.79
0.270 1.518%
Share volume: 2,370,148
Last Updated: 03-04-2026
Healthcare/Services – Health:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$17.52
0.27
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-10-2024 | 08-07-2024 | 11-12-2024 | 03-03-2025 | 05-09-2025 | 11-07-2025 | 02-27-2026 | |
| Total revenue | 278.078 M | 304.087 M | 286.625 M | 298.431 M | 324.038 M | 313.346 M | 318.403 M | |
| Cost of revenue | 215.672 M | 235.806 M | 227.381 M | 234.999 M | 248.243 M | 240.511 M | 241.522 M | |
| Gross profit | 62.406 M | 68.281 M | 59.244 M | 63.432 M | 75.795 M | 72.835 M | 76.881 M | |
| 9.41% | -13.24% | 7.07% | 19.49% | -3.91% | 5.56% | |||
| Operating expenses | 28.429 M | 31.173 M | 30.329 M | 32.029 M | 33.839 M | 33.373 M | 43.672 M | |
| Selling general and admin | 28.429 M | 31.173 M | 30.329 M | 32.029 M | 33.839 M | 33.373 M | 43.672 M | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 43.883 M | 47.594 M | 46.786 M | 47.645 M | 51.625 M | 51.308 M | 61.659 M | |
| 8.46% | -1.70% | 1.84% | 8.35% | -0.61% | 20.17% | |||
| Operating income | 18.523 M | 20.687 M | 12.458 M | 15.787 M | 24.170 M | 21.527 M | 15.222 M | |
| Ebit | 21.883 M | 24.251 M | 17.962 M | 19.106 M | 26.537 M | 23.964 M | 17.854 M | |
| Pretax income | 22.515 M | 25.067 M | 17.962 M | 17.658 M | 26.537 M | 23.964 M | 17.854 M | |
| 11.33% | -28.34% | -1.69% | 50.28% | -9.70% | -25.50% | |||
| Income tax | 5.617 M | 8.582 M | 7.541 M | 7.126 M | 11.478 M | 10.100 M | 5.369 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 16.898 M | 16.485 M | 10.421 M | 10.532 M | 15.059 M | 13.864 M | 12.485 M | |
| -2.44% | -36.78% | 1.07% | 42.98% | -7.94% | -9.95% |